安道麥B: 關(guān)于關(guān)聯(lián)方25000萬(wàn)美元信用貸款暨關(guān)聯(lián)交易的公告（英文版）|世界時(shí)快訊

      Stock Code: 000553(200553)          Stock Abbreviation: ADAMA A (B)             NO. 2023-6

(資料圖片僅供參考)

                                        ADAMA Ltd.

             Announcement on Credit Facility of USD 250

                   million from a Related Party

 The Company and all members of the Company’s Board of Directors confirm that all information

 disclosed herein is true, accurate and complete, with no false or misleading statement or material

 omission.

The Company and all members of the Company’s Board of Directors confirm that all information

disclosed herein is true, accurate and complete, with no false or misleading statement or material

   I.

omission. Overview of the Related Party Transaction

         On February 15, 2023, the 18th meeting of the 9th session of the Board of Directors of

         ADAMA Ltd. (hereinafter referred to as the “Company”) approved entering into an

         additional Credit Facility Agreement, following the previously approved Credit

         Facility Agreement, entered into by and between Syngenta Group (NL) B.V.

         ( hereinafter referred to as "SG NL"), a subsidiary of the Company"s controlling

         shareholder, Syngenta Group Co., Ltd. (hereinafter referred to as "SG"), and Adama

         Fahrenheit B.V. ( hereinafter referred to as "ADAMA NL"), an indirectly wholly-

         owned subsidiary of the Company, as amended (please refer to Announcements on

         Credit Facilities from a Related Party (Announcement No. 2021-46 and 2022-32) for

         details), according to which SG NL shall provide an additional amount of USD 250

         million (to an aggregate amount of USD 350 million committed short-term credit

         facility) in favor of ADAMA NL (the "Transaction").

         Since SG NL and ADAMA NL are both controlled by SinoChem Holding Co., Ltd.

         (hereinafter referred to as "SinoChem Holding”), the Transaction constitutes a related

         party transaction.

         Among the five directors of the Company, the related-party directors, Mr. Erik Fyrwald

         and Mr. Chen Lichtenstein refrained from voting, while among the remaining votes of

         the three directors, there were three (3) affirmative votes, and no negative votes and or

         abstentions. The independent directors also issued their independent opinion.

       The Transaction requires the approval of the Company’s shareholders. SG will refrain

       from voting.

       The Transaction does not constitute a Material Assets Restructuring as stipulated by

       the Administrative Measures on Significant Asset Restructuring of Listed Companies.

II.    Introduction to the Related Party

       SG NL was established in 2016. Its legal representative is Edwin Pool, and its

       registered address is Westeinde 62, 1601BK Enkhuizen, The Netherlands. It has

       registered capital of EUR 1 and mainly undertakes the businesses related to holding

       activities. The main financial data as of December 31, 2021 is: operating revenue of

       USD 0, net profit of USD 383,747,000, total assets of USD 43,141,531,000, net assets

       of USD 41,294,980,000.

       Related-party relationship: Both SG NL and ADAMA NL are controlled by

       SinoChem Holding, the ultimate controlling shareholder of the Company. SG NL is

       related party of the Company in accordance with Item 2, Paragraph 2 of Article 6.3.3

       of the Listing Rules of Shenzhen Stock Exchange.

       Analysis of contract performance capability: To the best of the Company’s knowledge,

       SG NL operates normally and is in good operational condition. After searching on the

       website of disclosure of enforcement information of China, it is not a debtor subject

       to judicial enforcement.

III.   Basic Information on the Target of the Related-Party Transaction

       The Transaction is an engagement in a USD 250 million short-term committed

       annually revolving credit line, at 3-month CME Term SOFR Reference Rate + 1.8%.

       By engaging in the Transaction, the total short-term committed credit facilities

       provided by the related party shall be in the aggregate amount of USD 350 million

       (the "Credit Facility Agreements”), and the interest rate thereof shall bear the

       interest rate set herein.

IV.    Pricing Basis of the Related-Party Transaction

       The Transaction is made on the principles of voluntariness, equality, mutual benefit,

       justice and fairness. The terms of the Transaction were negotiated fairly on the basis

       of market practice.

V.    Main Contents of the Credit Facility Agreements

      Contract Name: Credit Facility Agreement by and between Adama Fahrenheit B.V.

      and Syngenta Group (NL) B.V.

      Borrower: Adama Fahrenheit B.V.

      Lender: Syngenta Group (NL) B.V.

      Main Terms: committed short-term credit facility in the aggregate amount of USD

      million previously approved (please refer to Announcement on Credit Facilities from

      a Related Party (Announcement No. 2021-46) for details); (2) USD 50 million

      previously approved (please refer to Announcement on Credit Facilities from a

      Related Party (Announcement No. 2022-32) for details); and (3) the herein detailed

      USD 250 million short-term committed annually revolving credit line, at 3-month

      CME Term SOFR Reference Rate + 1.8%. Both parties may assign their rights and

      obligations under the Credit Facility Agreements to another entity within their

      respective group according to the terms of the Credit Facility Agreements.

      Effective Date of the Agreement: following the approval of the Board of Directors

      and the Shareholders of the Company and subject to the approvals of ADAMA NL’s

      group requisite organs, as required. The requisite organs of the Company will review

      the terms relating to the aggregated USD 350 million short-term revolving credit line

      every three years.

      Dispute Resolutions: Any controversy or claim that fails to be solved amicably shall

      be finally submitted to the competent courts of Amsterdam under the laws of

      Netherlands.

VI.   Purpose of the Transaction and Its Impact on the Company

      The Transaction expands and efficiently utilizes the Company"s and its subsidiaries

      funding sources with committed facilities providing an additional cash source not

      included in bank covenants. The Credit Facility Agreements follow the general practice

      of similar transactions in the market and doesn’t contain unfair terms. The Transaction

      will not adversely affect the interests of the Company and its non-related party

      shareholders, nor will it affect the independence of the Company.

VII. Status of the Different Kind of Related Party Transactions between the Company

      and SinoChem Holding

      The related party transactions between the Company and subsidiaries of Sinochem

      Holding are as follows:

        with subsidiaries of SinoChem Holding in the ordinary course of business is RMB

        business approved by the 2021 annual shareholders meeting is RMB 5,141.09m.

         Ltd.: As of the date of this announcement, the balance of deposits remains RMB

         shareholders meeting of the Company in 2022.

VIII. Independent Directors’ Opinions

      The Company’s independent directors have given separate opinions on the Transaction:

      The Transaction is based on the funding needs of the Company and is normal business

      operations. The Transaction conforms to relevant national laws and regulations, as

      applicable, and market-oriented principles, and will not impact the independence of the

      Company or harm the interests of the Company and its other shareholders. The decision-

      making procedures for the Transaction conform to the Company Law, the Rules of

      Shenzhen Stock Exchange for the Listing of Stocks, the Articles of Association of the

      Company and other laws and regulations. Therefore, the independent directors approved

      the Transaction.

IX.   Documents for Future Reference

         Company;

      It is hereby announced.

                                                    The Board of Directors of ADAMA Ltd.

                                                                            February 16, 2023

查看原文公告

標(biāo)簽： 關(guān)聯(lián)交易